Skip to Main Content

Paper Details

A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells.
NAR Cancer
17
2021
BCLAF1-L, CLK kinases, CLK1, CLK4 kinases, CRC, CRC cell lines, CRC cells, GPS167, GPS167/192, GPS192, HCT116 cells, MDM2, MDM4, NAB2, SLK1, SRSF10, TRA2A, WTAP, aminothiazole carboxamide, colorectal cancer, human, human colorectal cancer cells, metastatic colorectal cancer, normal colonocytes, p53
Author NameAffiliation
Jasmin Coulombe-HuntingtonInstitute for Research in Immunology and Cancer, Universite de Montreal
Mike TyersInstitute for Research in Immunology and Cancer, Universite de Montreal
Mike TyersInstitute for Research in Immunology and Cancer, Universite de Montreal
Benoit ChabotUniversite de Sherbrooke. Sherbrooke
  • 1 - 4

Datasets

Release 1.2